The United Nations Commission on Narcotic Drugs (UN-CND) has no right to classify industrial hemp as a potential narcotic, according to the European Industrial Hemp Association (EIHA), which has requested for the provision of a transparent global legal framework for industrial hemp.
In a press release, EIHA said that as per the UN Single Convention on Narcotic Drugs, the United Nations Commission on Narcotic Drugs is not permitted to classify industrial hemp as a possible narcotic because hemp is not subject to international drug controls. EIHA further noted that industrial hemp has never been listed in that document nor the supplementary procedures.
EIHA’s President Daniel Kruse said that the Single Convention continuity of the witch hunt on hemp products, which is ongoing, is absurd and lacks any basis.
The statement made by EIHA came after the UN-CND concluded its 63rd Session of the UN’s Commission on Narcotic Drugs, which was held in Vienna. The commission agreed to postpone a critical international vote that could have allowed governments to have clear guidance as they establish rules for hemp-based products such as plant-derived CBD and other extracts. The association released a paper titled “The common position of the hemp industries on the international drug control system.” According to the Association, the article provides clear evidence that industrial hemp is not classified within the scope of the 1961 Single Convention.
The Single Convention is an international treaty (C61) that forms the basis of global drug controls. In the agreement, marijuana is defined as the ‘flowering of the fruit.’ EIHA noted that the definition means that the seeds and leaves are all derived products and, therefore, cannot be classified as drugs nor as medicine.
According to EIHA, industrial hemp should be defined as a marijuana plant with insignificant levels of THC, which is cultivated for industrial use because of its non-psychotic derivatives. Furthermore, hemp products and extracts should be defined as non-toxicological products or preparations from marijuana plants with insignificant levels of THC, which is grown specifically for industrial use.
EIHA further noted that as per Article 2(9) of the Single Convention, hemp products obtained from the ‘Flowering and Fruiting top’ of Cannabis Sativa L. plants should also be exempted from narcotic classification. EIHA further said the use of drugs in industrial sectors for non-medical and non-scientific purposes is also excluded from the Single Convention.
EIHA’s Managing Director Lorenza Romanese said that in the face of international market developments for hemp products, industrial hemp must be decriminalized to recognize its importance as an agricultural crop and industrial plant. Romanese also noted that industrial hemp products are not drugs nor medicines and that they do not lead to addiction or dependence.
Analysts believe that the position of the European Industrial Hemp Association may be echoing what North American hemp industry actors like SinglePoint Inc. (OTCQB: SING) think about the way hemp products should be regulated.
About HempWire
HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.
To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.hempwire.com
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/Disclaimer
Do you have a questions or are you interested in working with HW? Ask our Editor
HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net
HempWire is part of the InvestorBrandNetwork.
